01 2Allergan Inc.
02 2Borden Ladner Gervais LLP
03 3Ferring Inc.
04 3Gowling WLG (Canada) LLP
01 12111697
02 12359812
03 12377299
04 12444814
05 22462905
06 12648658
07 12687130
08 12871016
09 12923063
01 15-Aminosalicylic Acid
02 4MESALAZINE
03 2Mesalamine
04 3Mesalazine
01 2Enteric Coated Tablet
02 1Suppositories
03 4TABLET (DELAYED-RELEASE)
04 2Tablet
05 1Tablet (Delayed and Extended Release)
01 12012-06-16
02 12020-06-08
03 22021-10-15
04 22021-10-24
05 12027-04-13
06 12027-05-27
07 12033-04-29
08 12033-10-29
Patent Expiration Date : 2021-10-24
Date Granted : 2009-06-09
Brand Name : ASACOL 800
Patent Number : 2444814
Filing Date : 2001-10-24
Strength per Unit : 800mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-10-24
Date Granted : 2009-06-09
Patent Expiration Date : 2021-10-24
Date Granted : 2004-02-10
Brand Name : ASACOL 800
Patent Number : 2359812
Filing Date : 2001-10-24
Strength per Unit : 800mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-10-24
Date Granted : 2004-02-10
Patent Expiration Date : 2012-06-16
Date Granted : 2002-08-20
Brand Name : PENTASA
Patent Number : 2111697
Filing Date : 1992-06-16
Strength per Unit : 1 g
Dosage Form : Suppositories
Human Or VET : Human
Route of Administration : Rectal
Patent Expiration Date : 2012-06-16
Date Granted : 2002-08-20
Patent Expiration Date : 2021-10-15
Date Granted : 2011-04-12
Brand Name : PENTASA
Patent Number : 2462905
Filing Date : 2001-10-15
Strength per Unit : 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-10-15
Date Granted : 2011-04-12
Patent Expiration Date : 2021-10-15
Date Granted : 2011-04-12
Brand Name : PENTASA
Patent Number : 2462905
Filing Date : 2004-04-05
Strength per Unit : 1g
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-10-15
Date Granted : 2011-04-12
Patent Expiration Date : 2020-06-08
Date Granted : 2009-05-12
Brand Name : MEZAVANT
Patent Number : 2377299
Filing Date : 2000-06-08
Strength per Unit : 1.2g
Dosage Form : Tablet (Delayed and Extended Release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-06-08
Date Granted : 2009-05-12
Patent Expiration Date : 2027-05-27
Date Granted : 2017-10-03
Brand Name : OCTASA
Patent Number : 2687130
Filing Date : 2007-05-07
Strength per Unit : 1600 mg
Dosage Form : TABLET (DELAYED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-05-27
Date Granted : 2017-10-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-04-13
Date Granted : 2013-11-12
Brand Name : OCTASA
Patent Number : 2648658
Filing Date : 2007-04-13
Strength per Unit : 1600 mg
Dosage Form : TABLET (DELAYED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-04-13
Date Granted : 2013-11-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-10-29
Date Granted : 2021-09-07
Brand Name : OCTASA
Patent Number : 2923063
Filing Date : 2013-10-29
Strength per Unit : 1600 mg
Dosage Form : TABLET (DELAYED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-10-29
Date Granted : 2021-09-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-04-29
Date Granted : 2023-03-21
Brand Name : OCTASA
Patent Number : 2871016
Filing Date : 2013-04-29
Strength per Unit : 1600 mg
Dosage Form : TABLET (DELAYED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-04-29
Date Granted : 2023-03-21
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
